To develop and deliver innovative treatment of brain disease, we work with a range of stakeholders. These include healthcare professionals, patients and their respective organizations. We collaborate on research, clinical development, exchange of scientific information, and marketing and sales activities.

These interactions are well-regulated by the national laws and industry association regulations that we integrate into our working processes, training and guidance.  

We are committed to transparency and our disclosed information follows the current laws or regulations from the industry associations we have joined, such as the European Federation of Pharmaceutical Industries and Associations (EFPIA).  

According to the Ethical rules for dialogue and negotiations with decision-makers published by Danish Ethical Committee for the Pharmaceutical Industry, every pharmaceutical company is obliged to publish a schedule on their website with the names of the PR or communication agencies, legal counsel or similar external consultancies acting on behalf of the pharmaceutical company to engage in dialogue and negotiations with decision-makers.

The following external consultants are representing H. Lundbeck A/S in dialogue and negotiation with decision makers:

Rud Pedersen Public Affairs
Christians Brygge 24, 3.
DK- 1559 København V

Lead Agency
Ravnsborg Tværggade 5c, 1.
DK-2200 København N

We have made the external agencies aware of the present set of rules and that the pharmaceutical company accepts responsibility for ensuring third party compliance therewith.

Here you can find an overview, together with the locations, of Lundbeck’s interactions with healthcare professionals and the related transfers of value: